Mereo BioPharma Group plc (MAH0) — Defensive Interval Ratio
Mereo BioPharma Group plc (MAH0) has a Defensive Interval Ratio of 225 days as of June 2023. Defensive assets of €10.74 Million (cash €-, short-term investments €-, receivables €10.74 Million) cover 225 days of daily cash needs of €47.83K/day. See how liquid is Mereo BioPharma Group plc's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Mereo BioPharma Group plc Defensive Interval Ratio (2016–2021)
This chart shows how Mereo BioPharma Group plc's Defensive Interval Ratio has evolved across 6 annual periods from 2016 to 2021. As of June 2023, the ratio stands at 225 days, meaning defensive assets of €10.74 Million can fund 225 days of operations without new revenue. See Mereo BioPharma Group plc (MAH0) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Mereo BioPharma Group plc (2016–2021)
The table below presents the year-by-year Defensive Interval Ratio for Mereo BioPharma Group plc from 2016 to 2021, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Mereo BioPharma Group plc market capitalisation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2021 | 53 days | €1.82 Million | €34.36K/day | €- | €- | ▼ -127 days |
| 2020 | 180 days | €4.23 Million | €23.47K/day | €- | €- | ▲ +38 days |
| 2019 | 143 days | €11.68 Million | €81.86K/day | €- | €0.00 | ▼ -40 days |
| 2018 | 183 days | €8.09 Million | €44.32K/day | €- | €2.50 Million | ▼ -230 days |
| 2017 | 412 days | €10.86 Million | €26.35K/day | €- | €2.50 Million | ▼ -248 days |
| 2016 | 660 days | €5.80 Million | €8.79K/day | €- | €- | — |